Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.
There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

UFS Leads ASGISA Training
2006-07-17

The University of the Free State (UFS) has been appointed as training service provider for the national programme for the creation of small enterprises and jobs in the second economy. This major national programme has a target of creating one million jobs for poor people in rural and peri-urban areas, which forms part of the government’s Accelerated and Shared Growth Initiative (ASGI-SA). The main method of training will be through the formation of self-help groups and cooperatives with access to business support and micro finance.

Prof Frans Swanepoel, Director of the UFS Research Development Directorate, acts as advisor to the national programme leader, Ms Vuyo Mahlati.  Dr Aldo Stroebel, senior researcher at the UFS Research Development Directorate, has been appointed as programme co-ordinator, based at the UFS. Prof Basie Wessels, Director of the  Mangaung-University Community Partnership Programme (MUCPP), has been appointed as the training co-ordinator and Ms Sazini Ndlovu as programme assistant based at the Independent Development Trust (IDT) in Pretoria.

Dr Stroebel has co-ordinated the development of a training programme, while Prof Wessels presented the “training-of-trainers” course at the MUCPP last month. This course was attended by trainers and trainer-assistants, identified and selected by the local economic development groups in each of the nine provinces, as well as trainers from Hand-in-Hand (HiH), an Indian non-governmental organisation acting as counterpart to the UFS in the provision of training.

Pictured here at the training session at the MUCPP were from the left: Prof Frans Swanepoel, Mr Gnanavel Mookkan (HiH), Dr Rendani Ralinala (IDT), Ms Sazini Ndlovu (national programme assistant), Mr Chinnaiah Meenakshisundaram (HiH), Dr Aldo Stroebel, Ms Vuyo Mahlati (national programme leader) and Prof Basie Wessels.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept